Israel’s PixCell (reported here previously) has partnered with Interreg Germany-Denmark’s Changing Cancer Care (CCC) initiative. They will assess PixCell’s HemoScreen hematology analyzer for cancer patients to perform blood tests as part of their homecare oncology treatment.
http://nocamels.com/2020/05/blood-test-device-home-chemo-treatments/